CAPLYTA

This brand name is authorized in United States

Active ingredients

The drug CAPLYTA contains one active pharmaceutical ingredient (API):

1 Lumateperone
UNII 70BSQ12069 - LUMATEPERONE

Lumateperone is an atypical antipsychotic used for the treatment of schizophrenia in adults. Its mechanism of action is unknown. However, the efficacy of lumateperone could be mediated through a combination of antagonist activity at central serotonin 5-HT2A receptors and postsynaptic antagonist activity at central dopamine D2 receptors.

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
CAPLYTA Capsule FDA, National Drug Code (US) MPI, US: SPL/PLR

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: US FDA, National Drug Code Identifier(s): 72060-142

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈